386 related articles for article (PubMed ID: 31173991)
41. The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
Allegretti J; Eysenbach LM; El-Nachef N; Fischer M; Kelly C; Kassam Z
Inflamm Bowel Dis; 2017 Oct; 23(10):1710-1717. PubMed ID: 28858073
[TBL] [Abstract][Full Text] [Related]
42. Fecal microbiota transplantation in children: a brief review.
Hourigan SK; Oliva-Hemker M
Pediatr Res; 2016 Jul; 80(1):2-6. PubMed ID: 26982451
[TBL] [Abstract][Full Text] [Related]
43. Fecal microbiota transplantation: History, procedure and regulatory considerations.
D T; Venkatesh MP
Presse Med; 2023 Dec; 52(4):104204. PubMed ID: 37944641
[TBL] [Abstract][Full Text] [Related]
44. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Haber SL; Raney CRK; Larson TL; Lau JP
Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
[TBL] [Abstract][Full Text] [Related]
45. Fecal microbiota transplantation: past, present and future.
Aroniadis OC; Brandt LJ
Curr Opin Gastroenterol; 2013 Jan; 29(1):79-84. PubMed ID: 23041678
[TBL] [Abstract][Full Text] [Related]
46. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.
Di Bella S; Gouliouris T; Petrosillo N
J Infect Chemother; 2015 Apr; 21(4):230-7. PubMed ID: 25703532
[TBL] [Abstract][Full Text] [Related]
47. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Kump P; Högenauer C
Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
[TBL] [Abstract][Full Text] [Related]
48. AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.
Peery AF; Kelly CR; Kao D; Vaughn BP; Lebwohl B; Singh S; Imdad A; Altayar O;
Gastroenterology; 2024 Mar; 166(3):409-434. PubMed ID: 38395525
[TBL] [Abstract][Full Text] [Related]
49. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
50. Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.
Gravito-Soares M; Gravito-Soares E; Portela F; Ferreira M; Sofia C
Rev Esp Enferm Dig; 2017 Jun; 109(6):473-476. PubMed ID: 28506071
[TBL] [Abstract][Full Text] [Related]
51. The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection.
Jalanka J; Hillamaa A; Satokari R; Mattila E; Anttila VJ; Arkkila P
Aliment Pharmacol Ther; 2018 Feb; 47(3):371-379. PubMed ID: 29226561
[TBL] [Abstract][Full Text] [Related]
52. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
53. Fecal transplantation - the new, inexpensive, safe, and rapidly effective approach in the treatment of gastrointestinal tract diseases.
Oprita R; Bratu M; Oprita B; Diaconescu B
J Med Life; 2016; 9(2):160-2. PubMed ID: 27453747
[TBL] [Abstract][Full Text] [Related]
54. [Customised infectiology - Fecal microbiota transplantation : following the
Galperine TK; Guery B
Rev Med Suisse; 2019 Apr; 15(646):776-779. PubMed ID: 30969490
[TBL] [Abstract][Full Text] [Related]
55. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent
Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ;
United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950
[TBL] [Abstract][Full Text] [Related]
56. The Route to Palatable Fecal Microbiota Transplantation.
Fadda HM
AAPS PharmSciTech; 2020 Apr; 21(3):114. PubMed ID: 32296975
[TBL] [Abstract][Full Text] [Related]
57. Fecal microbiota transplantation for gastrointestinal disorders.
Malikowski T; Khanna S; Pardi DS
Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
[TBL] [Abstract][Full Text] [Related]
58. Fecal microbiota transplantation: indications, methods, evidence, and future directions.
Borody TJ; Paramsothy S; Agrawal G
Curr Gastroenterol Rep; 2013 Aug; 15(8):337. PubMed ID: 23852569
[TBL] [Abstract][Full Text] [Related]
59. Successful Fecal Microbiota Transplantation as an Initial Therapy for Clostridium difficile Infection on an Outpatient Basis.
Tanaka T; Kato H; Fujimoto T
Intern Med; 2016; 55(8):999-1000. PubMed ID: 27086820
[TBL] [Abstract][Full Text] [Related]
60. The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM
Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
